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Introduction: Kikuchi-Fujimoto disease, or histiocytic necrotizing lymphadenitis, is a rare, benign, autoimmune
condition characterized by lymphadenopathy, fever and neutropenia. It is a self-limited condition of unknown
etiology.
Case presentation: We report the case of a 45-year-old Caucasian man with the first known case of Kikuchi disease
associated with dramatic weight loss after bariatric surgery.
Conclusion: Although the association between Kikuchi disease and bariatric surgery may be entirely coincidental,
we speculate whether the immune dysfunction associated with weight loss may have played an etiologic role in
this process.Introduction
Histiocytic necrotizing lymphadenitis (HNL), also known
as Kikuchi or Kikuchi-Fujimoto disease, is a benign self-
limiting disease of unknown cause, characterized by benign
lymphadenopathy with associated fevers and systemic
symptoms [1]. The differential diagnosis with other types
of necrotizing lymphadenitis, such as systemic lupus
erythematosus (SLE), malignant lymphoma or pyogenic
infections, is established by identifying characteristic patho-
logic features from a lymph node biopsy specimen: para-
cortical necrosis with karyorrhectic foci of histiocytes,
plasmacytoid monocytes, immunoblasts, and small and
large lymphocytes with a predominance of T cells cluster
of differentiation (CD) 8+. The pathogenesis of HNL
remains controversial; it may be the result of a local
T-cell-mediated hyper-response to a variety of nonspeci-
fic stimuli, mostly viral infections [2]. Alternatively,* Correspondence: ricardogomezhuelgas@hotmail.com
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distribution, and reproduction in any mediummacrophages may infiltrate to repair the lymphoid tissue
injured by cytotoxic T cells [3]. We describe the case of a
patient who developed HNL after a laparoscopic Roux-en-
Y gastric bypass (RYGB) for morbid obesity. To the best of
our knowledge, this is the first such case reported in the
literature.
Case presentation
A 45-year-old Caucasian man presented with a three-
week history of a tender, slow-growing, left axillary lump,
associated with low-grade fever (37.5°C to 38°C) for the
last week. He had hypertension and was being treated with
lacidipine 4mg/day, lisinopril 10mg/day and hydrochlor-
othiazide 12.5mg/day. He smoked 30 cigarettes daily. Two
years earlier he had undergone a laparoscopic RYGB for
morbid obesity. Since that time he had lost 112kg and his
body mass index had fallen from 64.6kg/m2 to 28kg/m2.
He was receiving vitamins A, D and E, vitamin B complex,
calcium gluconate, cholecalciferol and iron supplements.
Our patient reported no family history of lymphoprolifera-
tive or autoimmune disease.
On examination, he had a tender, non-mobile, 3×4cm
lymphadenopathy in his left axillary region. His physicalntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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studies (complete blood count, erythrocyte sedimenta-
tion rate, coagulation tests, blood glucose, creatinine,
uric acid, sodium, potassium, lipids, liver parameters,
cytokeratin, lactate dehydrogenase, ferritin, serum C3 and
C4, antinuclear antibody, rheumatoid factor, C-reactive
protein, thyroid-stimulating hormone, urine tests and ser-
ology for herpes simplex virus 1 and 2, cytomegalovirus,
Epstein-Barr virus, hepatitis B and C virus, toxoplasma,
human herpes virus 8, parvovirus B19, human immuno-
deficiency virus 1 and human T-lymphotropic virus type
1) were normal and/or negative. A thoracoabdominal
computed tomography scan was normal except for the
axillary lymphadenopathy.
A lymph node biopsy showed coagulative necrosis and
frequent karyorrhexis with a lymphoplasmacytoid infiltrate
(Figure 1). An investigation for mycobacteria was negative.
This histological pattern is characteristic of HNL. No ther-
apy was given and one year later our patient was asymp-
tomatic and had experienced spontaneous complete
resolution of his axillary lymphadenopathy. After four
years of follow-up, our patient remains asymptomatic.
HNL is a disease with a world-wide distribution that
commonly affects young adults (in their 30s), and more
often affects women. The most frequent symptoms are
painful lymphadenopathy, primarily involving the cervical
lymph nodes, low-grade fever and malaise; arthromyalgias,
cutaneous rash, sweating and splenomegaly are infrequent.
Laboratory findings are nonspecific. Leukopenia is present
in 50% of cases, sometimes with atypical lymphocytes.Figure 1 Node biopsy (Giemsa stain). Fibrinoid necrosis - non-neutroph
lymphocytes and histiocytes with crescent nuclei resembling signet-ring ceThis entity should be differentiated from other lym-
phoproliferative, autoimmune and postinfectious causes
of lymphadenopathy. The diagnosis is established by
identifying characteristic pathologic features from a
lymph node biopsy: paracortical necrosis with karyor-
rhectic foci of histiocytes, plasmacytoid monocytes,
immunoblasts, and small and large lymphocytes with a
predominance of CD8+ T cells. Pathological examination
enables HNL to be differentiated from other types of
necrotizing lymphadenitis, such as SLE, malignant
lymphoma or pyogenic infections [1,4].
The pathogenesis of HNL is unknown but immune fac-
tors seem to be important. Some cases of HNL are asso-
ciated with immune diseases such as SLE, adult Still's
disease, Hashimoto thyroiditis or subacute lymphocytic
thyroiditis. Histological, ultrastructural and immunohis-
tochemical findings support a hyperimmune reaction as
the pathogenic mechanism of HNL.
HNL might represent a T-cell-mediated hyperimmune
response to several nonspecific stimuli in genetically sus-
ceptible people. The incidence of certain human leukocyte
antigen class II genes (DPA1*01 and DPB1*0202 alleles) is
significantly more frequent in Japanese patients with HNL
[5]. Viral agents (human herpes virus 6 and 8, Epstein-
Barr virus, parvovirus B19, human T-lymphotropic virus
type-1), bacteria and protozoa have all been implicated in
the etiology but the supportive data are controversial [2].
Physicochemical factors (pacemaker implantation, sili-
cone breast implant) have been anecdotally related with
HNL [6].ilic with apoptotic bodies, cellular debris and a palisade of large
lls.
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outcome within a few months is the rule. A short course
of steroid therapy may be indicated if HNL is very symp-
tomatic. However, patients must be followed-up over the
long term because SLE can develop several years after
the diagnosis of HNL [4].
Bariatric surgery is currently the only curative option
for morbid obesity and the number of people living with
bariatric surgery has increased exponentially since the
mid-1990s. However, we are still not aware of all the
long-term side effects associated with this procedure.
In this case, we report what we believe to be the first
case of HNL after bariatric surgery. Nevertheless, we
cannot discount the existence of other cases of HNL that
did not have a pathologic diagnosis and may not have
been reported because their courses were only mildly
symptomatic and resolved spontaneously.
The association between HNL and bariatric surgery
may be casual, but we cannot discard an immunological
reaction secondary to RYGB. The effect of bariatric sur-
gery on the immune system is unclear. It is well known
that starvation can suppress the immune function, and
partial lipectomy in rodents impairs humoral immunity
[7]. Some data suggest that weight loss induced by bar-
iatric surgery can modulate the immune system. The
majority of studies addressing the effect of bariatric sur-
gery on immune function have focused on inflamma-
tion markers. After RYGB, there is a decline in the
levels of inflammatory cytokines such as interleukin
(IL)-6 [8], IL-18 and tumor necrosis factor alpha [9].
Additionally, an increase in blood monocytes and a re-
duction in circulating dendritic cells after RYGB have
also been reported [10]. Other authors have found a re-
duction in CD95 expression, a molecule involved in the
induction of apoptosis, and an increase in CD62L (L-
selectin) expression markers one year after RYGB [11].
In another study, levels of monocyte chemoattractant
protein-1 and interferon gamma, which are important
components of the immune response to infectious
pathogens, were restored after weight loss induced by
RYGB [12]. Furthermore, natural killer cell activity, in-
nate immune cells involved in the control of cancer
and infections, was enhanced after RYGB [13]. Recently,
an inverse relationship between the change in certain T
cells (CD4+ and CD3+) and the amount of weight lost
after gastric bypass surgery has been noted [14]. Finally,
bariatric surgery leads to strongly reduced leptin levels
and this hypoleptinemic state may impair the immune
system and increase the postoperative complications of
bariatric surgery [15].
Conclusion
Although the association of HNL and RYGB may be en-
tirely coincidental, we cannot rule out that a hyperimmuneresponse to extreme weight loss after bariatric surgery may
lead to the development of HNL in predisposed patients.
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